7Pasternak RC,Smith SC,Bairey-Merz CN,et al.Lenfant,ACC/AHA/NHLBI clinical advisory on the use and safety of statins[J].Stroke,2002,33(9):2337-2341. 被引量：1
8Graham DJ,Staffa JA,Shatin D,et al.Incidence of hospitalized rhabdomyolysts in patients treated with lipid-lowering drugs[J].JAMA,2004,292(21):2585-2590. 被引量：1
9Baigent C,Landray M,Leaper C,et al.First United Kingdom Heart and Renal Protection(UK-HARP-I)study:biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease[J].Am J Kidney Dis,2005,45:473-484. 被引量：1
10Holdaas H,Wanner C,Ablet C,et al.The effect of fluvastatin on cardiac outcome in patients with moderate to severe renal insufficiency:a pooled analysis of double-blind,randomized trial[J].Int J Cardiol,2006,54(2):211. 被引量：1
9Khan FY, Ibrahim W. Rosuvastatin induced rhabdomyoyysis in a low risk patient: a case report and review of the literature[ J ]. Curr Clin Pharmacol, 2009, 4 ( 1 ) : 1-3. 被引量：1
10Moreno A, Fort~n J, Graus J, et al. Severe rhabdomyolysis due to rosuvastatin in a liver transplant subject with human immunodeficiency virus and immunosuppressive therapy-related dyslipidemia [ J]. Liver Transpl, 2011 (17) : 331-333. 被引量：1
